Pfizer sells £3B of shares in Haleon (NYSE:PFE)

Pfizer (NYSE:PFE) has sold over £3 billion ($3.8 billion) of shares in Haleon (NYSE:HLN), thereby reducing its interest in the consumer health firm from 32% to approximately 22.6%.

The U.S. drugmaker sold around 790.55M Haleon (HLN) ordinary shares, of which 594M are ordinary shares sold at a price to the public of £3.08 each. The remaining 196.55M are ordinary shares in the form of American Depositary Shares (ADS), sold at $7.85 per ADS.

The post Pfizer sells £3B of shares in Haleon (NYSE:PFE) first appeared on Investorempires.com.

 

Borrower scores improve in a year | Investorempires.com

Read More | Economy Borrower scores improve in a year Thursday March 21 2024 Credit scores for individual borrowers standing above good or 500 to 900 points have climbed to 71 percent or 16.3 million profiles Individual credit scores have strengthened despite concerns of elevated credit risks from rising interest rates in the past year. […]

Today’s replay link [big turnout] | Raging Bull

Read More |    Here’s the replay from today’s 11 AM ET training. Big turnout with over 788 traders. Thanks for coming out today guys and gals. Not a member? What are you waiting for! Start your Journey today. OVERVIEW My strategy or edge stacks probability. Just like bookmakers (DraftKings), casinos (MGM Grand) and insurance […]